Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
1.1
USD
3.77%
Market Closed
Market Cap:
$1.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
US |
|
A
|
ams-OSRAM AG
VSE:AMS2
|
AT |
|
National Health Investors Inc
NYSE:NHI
|
US |
|
CPS Technologies Corp
NASDAQ:CPSH
|
US |
|
Escorts Kubota Ltd
NSE:ESCORTS
|
IN |
|
Victoria's Secret & Co
NYSE:VSCO
|
US |
|
I
|
Intchains Group Ltd
NASDAQ:ICG
|
CN |
|
China Resources Beer Holdings Co Ltd
HKEX:291
|
HK |
|
Northeast Community Bancorp Inc
NASDAQ:NECB
|
US |
Wall St Price Targets
SNOA Price Targets Summary
Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals Inc
Wall Street analysts forecast SNOA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for SNOA is 15.1 USD with a low forecast of 14.95 USD and a high forecast of 15.54 USD.
Lowest Forecast
Price Target
14.95
USD
1 259% Upside
Average Forecast
Price Target
15.1
USD
1 272% Upside
Highest Forecast
Price Target
15.54
USD
1 313% Upside
Sonoma Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNOA's stock price target?
Price Target
15.1
USD
15.1
USD
According to Wall Street analysts, the average 1-year price target for SNOA is 15.1 USD with a low forecast of 14.95 USD and a high forecast of 15.54 USD.
What is the Revenue forecast for Sonoma Pharmaceuticals Inc?
Projected CAGR
24%
24%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 24%.
